DexCom (NASDAQ:DXCM) Earns Outperform Rating from Analysts at Mizuho
Investment analysts at Mizuho assumed coverage on shares of DexCom (NASDAQ:DXCM – Get Free Report) in a note issued to investors on Thursday, Marketbeat reports. The brokerage set an “outperform” rating and a $85.00 price target on the medical device company’s stock. Mizuho’s price objective indicates a potential upside of 28.52% from the stock’s previous […]
Investment analysts at Mizuho assumed coverage on shares of DexCom (NASDAQ:DXCM – Get Free Report) in a note issued to investors on Thursday, Marketbeat reports. The brokerage set an “outperform” rating and a $85.00 price target on the medical device company’s stock. Mizuho’s price objective indicates a potential upside of 28.52% from the stock’s previous […]
